Upcoming Webinars

Maximizing Value in Early-Phase Oncology Trials: Innovative Endpoints for Early Insights

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Pharma,
  • February 25, 2026 | 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
  • 60 min

Upcoming Webinars

From FIH to POC — Designing Phase I/Ib Trials with Efficiency

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Patient Recruitment & Retention, Pharma,
  • February 25, 2026 | 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
  • 60 min

Upcoming Webinars

Responsible Data Return in Rare Disease Clinical Trials: What Sponsors Need to Know

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Pharma,
  • February 26, 2026 | 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
  • 60 min

Upcoming Webinars

Engaging Community Voices to Improve Clinical Trial Access

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Patient Recruitment & Retention, Pharma,
  • February 26, 2026 | 1pm EST (10am PST)
  • 60 min

Upcoming Webinars

How to Safely Harness R and SAS for Cutting-Edge and Validated Clinical Analytics

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Pharma,
  • February 26, 2026 | 2pm EST (1pm CST / 11am PST)
  • 60 min

Upcoming Webinars

February 25, 2026

Maximizing Value in Early-Phase Oncology Trials: Innovative Endpoints for Early Insights
February 25, 2026

From FIH to POC — Designing Phase I/Ib Trials with Efficiency
February 26, 2026

Responsible Data Return in Rare Disease Clinical Trials: What Sponsors Need to Know
February 26, 2026

Engaging Community Voices to Improve Clinical Trial Access
February 26, 2026

How to Safely Harness R and SAS for Cutting-Edge and Validated Clinical Analytics
February 27, 2026

Peptide Synthesis: New Sustainable Strategies for Regulatory and Market Demands
February 27, 2026

3 Key Trends Transforming the Future of Rare Disease Clinical Development
February 27, 2026

Overcoming Disruptions in the Life Sciences Supply Chain with Unified Platforms
March 03, 2026

When patients lead: Breaking barriers in ultra-rare disease drug development
March 03, 2026

Embracing the Transformative Role of AI in Driving RWD Adoption
March 04, 2026

Preventing Blood Bag Breakage & Reducing Risk in Complex Cold Chains
March 04, 2026

Accelerate Your Study: Harnessing AI and Automation for Rapid Study Start-up
March 05, 2026

QSIT Is Ending: How to Achieve Audit Readiness for Medical Devices Under FDA QMSR
March 05, 2026

The ART of Market Entry: Navigating Japan’s Pharmaceutical Landscape
March 10, 2026

Novel Digital Endpoint Solutions for Early and Mid-Phase Development
March 10, 2026

Drug Development Lessons for 2026 Drawn from 2025 Realities